These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 1356555)

  • 1. A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
    Grenader A; Healy DP
    Br J Pharmacol; 1992 Jun; 106(2):229-30. PubMed ID: 1356555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fenoldopam is a partial agonist at dopamine-1 (DA1) receptors in LLC-PK1 cells.
    Grenader A; Healy DP
    J Pharmacol Exp Ther; 1991 Jul; 258(1):193-8. PubMed ID: 1677038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A68930: a potent agonist selective for the dopamine D1 receptor.
    DeNinno MP; Schoenleber R; MacKenzie R; Britton DR; Asin KE; Briggs C; Trugman JM; Ackerman M; Artman L; Bednarz L
    Eur J Pharmacol; 1991 Jun; 199(2):209-19. PubMed ID: 1683288
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular and renal hemodynamic effects of A-68930 in the conscious dog: a comparison with fenoldopam.
    Christie MI; Smith GW
    J Pharmacol Exp Ther; 1994 Feb; 268(2):565-70. PubMed ID: 7906731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of behavioural responses to SK&F 83959 in relation to 'D1-like' dopamine receptors not linked to adenylyl cyclase.
    Deveney AM; Waddington JL
    Br J Pharmacol; 1995 Oct; 116(3):2120-6. PubMed ID: 8640354
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dopamine D1 receptor agonists, A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat.
    Trampus M; Ferri N; Adami M; Ongini E
    Eur J Pharmacol; 1993 Apr; 235(1):83-7. PubMed ID: 8100197
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the dopamine receptor expressed by rat glomerular mesangial cells in culture.
    Bryson SE; Drew GM; Hall AS; Ball SG; Balmforth AJ
    Eur J Pharmacol; 1992 Jan; 225(1):1-5. PubMed ID: 1347268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. cAMP-independent, G protein-linked inhibition of Na+/H+ exchange in renal brush border by D1 dopamine agonists.
    Felder CC; Albrecht FE; Campbell T; Eisner GM; Jose PA
    Am J Physiol; 1993 Jun; 264(6 Pt 2):F1032-7. PubMed ID: 8100686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid reversal of denervation supersensitivity of dopamine D1 receptors by l-dopa or a novel dopamine D1 receptor agonist, A68930.
    Britton DR; Kebabian JW; Curzon P
    Eur J Pharmacol; 1991 Jul; 200(1):89-93. PubMed ID: 1685124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopamine receptor agonists and antagonists both inhibit dopamine secretion in LLC-PK1 cells.
    Dawson R; Felheim R; Phillips MI
    Eur J Pharmacol; 1993 Aug; 240(2-3):277-82. PubMed ID: 7902285
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of Na+,K(+)-ATPase in rat renal proximal tubules by dopamine involved DA-1 receptor activation.
    Chen C; Lokhandwala MF
    Naunyn Schmiedebergs Arch Pharmacol; 1993 Mar; 347(3):289-95. PubMed ID: 8097567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of dopamine agonist-induced phosphoinositide hydrolysis by concomitant stimulation of cyclic AMP formation in brain slices.
    Undie AS; Friedman E
    J Neurochem; 1994 Jul; 63(1):222-30. PubMed ID: 7911510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. D1 agonists suppress zero Mg(2+)-induced epileptiform activity in the rat cingulate cortex slice.
    Alam AM; Starr MS
    Neuroreport; 1993 Oct; 5(1):78-80. PubMed ID: 7506591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of catechol ring fluorination on cardiovascular and renal activities of fenoldopam enantiomers.
    Kinter LB; Mann WA; Weinstock J; Ruffolo RR
    Chirality; 1994; 6(5):446-55. PubMed ID: 7915128
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dopamine receptor activation in bovine pinealocyte via a cAMP-dependent transcription pathway.
    Santanavanich C; Ebadi M; Govitrapong P
    J Pineal Res; 2005 Apr; 38(3):170-5. PubMed ID: 15725338
    [TBL] [Abstract][Full Text] [Related]  

  • 16. D1 dopamine receptor activity of anti-parkinsonian drugs.
    Fici GJ; Wu H; VonVoigtlander PF; Sethy VH
    Life Sci; 1997; 60(18):1597-603. PubMed ID: 9126882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A68930: a potent agonist specific for the dopamine D1 receptor.
    Kebabian JW; DeNinno MP; Schoenleber R; MacKenzie R; Britton DR; Asin KE
    Neurochem Int; 1992 Mar; 20 Suppl():157S-160S. PubMed ID: 1365416
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The dopamine D1 receptor is expressed and facilitates relaxation in airway smooth muscle.
    Mizuta K; Zhang Y; Xu D; Mizuta F; D'Ovidio F; Masaki E; Emala CW
    Respir Res; 2013 Sep; 14(1):89. PubMed ID: 24004608
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The selective dopamine D1 receptor agonist SK&F 38393: its effects on palatability- and deprivation-induced feeding, and operant responding for food.
    Rusk IN; Cooper SJ
    Pharmacol Biochem Behav; 1989 Sep; 34(1):17-22. PubMed ID: 2576310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
    Witkin JM; Newman AH; Nowak G; Katz JL
    J Pharmacol Exp Ther; 1993 Oct; 267(1):266-74. PubMed ID: 7901394
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.